Table 1.
Patient baseline demographic and clinical characteristics.
| Variables | RIPC (n = 7) |
|---|---|
| Age, median (IQR), years | 59 (56–64) |
| Race, white (%) | 6 (86%) |
| Intracranial aneurysm treatment | |
| PED (flow diversion) | 2 (29%) |
| Coil (endosaccular coiling) | 4 (57%) |
| Combined coiling and PED | 1 (14%) |
| Cuff-related complications | 2 (29%) |
| AF, N (%) | 0 (0) |
| DM, N (%) | 0 (0) |
| Hypertension, N (%) | 2 (29%) |
| Current smoking, N (%) | 5 (71%) |
| CHF, N (%) | 0 (0) |
| CAD, N (%) | 0 (0) |
| Hyperlipidemia, N (%) | 1 (14%) |
| Median (IQR) time from RIPC administration to endovascular procedure (minutes) | 180 (76–265) |
| Interval between the endovascular procedure and post-endovascular imaging (hours) | 28 (24.26–31.25) |
| Pre-EVT DAPT | 7 (100%) |
| Post-EVT DAPT | 7 (100%) |
AF: atrial fibrillation; CAD: coronary artery disease; CHF: congestive heart failure; DAPT: dual antiplatelet therapy (aspirin (325 mg) plus clopidogrel); DM: diabetes mellitus; EVT: endovascular treatment; IQR: interquartile range; PED: pipeline embolization device; RIPC: remote ischemic preconditioning.